Show side menu

Plataforma in vitro lab NBS3 CReSA - Platform for in vitro, in vivo and ex vivo monitoring of infections in high biocontainment (NBS3)

Starting date: 01/06/2021 End date: 31/12/2023
Programme: Animal Health

Financing entities:

This proposal is focused on improving the service in animal experimentation and the analysis of samples infected by NBS3 pathogens. The acquisition of a telemetry system based on the implantation of micro-sensors in large animals will make it possible to monitor physiological parameters in real-time during infections.